Science Explorer Interactive view Map
Company · Cambridge · United States

Acceleron Pharma (United States)

acceleronpharma.comROR OpenAlex
World rank, all time
#27,916
of 42,892
Rank in United States
#5,993
of 8,685
Research works
192
▲ 16% vs 2013–17
Citations
6.1k
32.0 per fractional work
Top-10% rate
12.8%
record average 16.5%
Open access
30%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.50× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.88× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 0.51× its world share, 0 worksImmunology and Micro…Neuroscience: 0.17× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.07× its world share, 0 worksPharmacology, Toxico…Engineering: 1.91× its world share, 9 worksEngineeringEnvironmental Science: 0.54× its world share, 1 worksEnvironmental ScienceMathematics: 0.92× its world share, 0 worksMathematicsPhysics and Astronomy: 8.03× its world share, 6 worksPhysics and AstronomyMedicine: 2.04× its world share, 12 worksMedicineVeterinary: 0.27× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.08× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 0.63× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Physics and Astronomy, 8.0×. Every wedge is a field page.

Who are the top researchers at Acceleron Pharma (United States)?

Ranked on the composite score, Ravi Kumar and Malaya Kumar Biswal M lead among researchers whose main affiliation is Acceleron Pharma (United States).

  1. 1 Ravi Kumar United States · #990,885 worldwide 70 citations · 49 works
  2. 2 Malaya Kumar Biswal M United States · #1,376,202 worldwide 16 citations · 29 works
All ranked researchers at Acceleron Pharma (United States)

Which keywords describe research at Acceleron Pharma (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Echocardiography, Pulmonary Hypertension, Chronic Kidney Disease, Endothelial Dysfunction, Right Heart Assessment, Treatment Guidelines, CubeSat and small satellite.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 31 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 31 words, with their numbers
  1. Echocardiography4▲ 44×2 topics
  2. Pulmonary Hypertension3▲ 63×2 topics
  3. Chronic Kidney Disease3▲ 35×2 topics
  4. Endothelial Dysfunction3▲ 36×2 topics
  5. Right Heart Assessment3▲ 208×1 topic
  6. Treatment Guidelines3▲ 39×1 topic
  7. CubeSat2▲ 408×1 topic
  8. small satellite2▲ 408×1 topic
  9. Space Policy2▲ 491×1 topic
  10. Space Tourism2▲ 491×1 topic
  11. Epidemiology2▲ 1.58×9 topics
  12. Biomechanics2▲ 20×2 topics
  13. Extravehicular Activity2▲ 697×1 topic
  14. Space Suit2▲ 697×1 topic
  15. Heart Failure2▲ 12×4 topics
  16. Immune Response2▲ 9.8×5 topics
  17. Pathogenesis2▲ 10×4 topics
  18. Obesity2▲ 6.6×4 topics
  19. Vaccine2▲ 12×4 topics
  20. Cardiovascular Risk1▲ 14×2 topics
  21. Hybrid Rocket Propulsion1▲ 196×1 topic
  22. Regression Rate Behavior1▲ 196×1 topic
  23. Mars1▲ 118×1 topic
  24. Martian Surface1▲ 118×1 topic
  25. Chamber Quantification1▲ 46×1 topic
  26. Diastolic Function1▲ 46×1 topic
  27. Fibrosis1▲ 19×3 topics
  28. On-Orbit Servicing1▲ 149×1 topic
  29. Solar System Abundances1▲ 67×1 topic
  30. Space Debris1▲ 149×1 topic
  31. Terrestrial Planets1▲ 67×1 topic

Which research topics does Acceleron Pharma (United States) publish most on?

By volume in 2022–2025: Pulmonary Hypertension Research and Treatments, Spacecraft Design and Technology, Space exploration and regulation and Space Exploration and Technology.

Pulmonary Hypertension Research and Treatments: 3 fractional worksSpacecraft Design and Technology: 2 fractional worksSpace exploration and re…2Space exploration and regulation: 2 fractional worksSpace Exploration and Te…2Space Exploration and Technology: 2 fractional worksRocket and propulsion systems research: 1 fractional worksPlanetary Science and Exploration: 1 fractional worksCardiovascular Function …1Cardiovascular Function and Risk Factors: 1 fractional worksSpace Satellite Systems and Control: 1 fractional worksAstro and Planetary Science: 1 fractional worksSpace Science and Extraterrestrial Life: 1 fractional works
Pulmonary and Respiratory MedicineAerospace EngineeringAstronomy and AstrophysicsCardiology and Cardiovascular Medicine

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Pulmonary Hypertension Research and Treatments Pulmonary and Respiratory Medicine 3 works
  2. 2 Spacecraft Design and Technology Aerospace Engineering 2 works
  3. 3 Space exploration and regulation Astronomy and Astrophysics 2 works
  4. 4 Space Exploration and Technology Aerospace Engineering 2 works
  5. 5 Rocket and propulsion systems research Aerospace Engineering 1 works
  6. 6 Planetary Science and Exploration Astronomy and Astrophysics 1 works
  7. 7 Cardiovascular Function and Risk Factors Cardiology and Cardiovascular Medicine 1 works
  8. 8 Space Satellite Systems and Control Aerospace Engineering 1 works
  9. 9 Astro and Planetary Science Astronomy and Astrophysics 1 works
  10. 10 Space Science and Extraterrestrial Life Astronomy and Astrophysics 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available30.5%not open69.5%

World: 28% of research is openly available.

with international co-authors19.0%domestic only81.0%

World: 19% is written across borders.

How has Acceleron Pharma (United States)'s research output changed?

Output in 2018–2022 was 16% higher than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.